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Allergic contact dermatitis to strong, low molecular 
weight contact allergens can regularly be induced in the 
hamster. By its clinical course, histopathology and sus-
ceptibility to intensification with complete Freund's ad-
juvant, this hypersensitivity appears congruent with the 
allergic contact dermatitis observed in other experimen-
tal animals and the allergic contact dermatitis seen in 
humans . 
Further, in the hamster, we find that pretreatment 
with cyclophosphamide intensifies the acquisition of al-
lergic contact dermatitis to dinitrochlorobenzene and to 
oxazolone ; the target of cyclophosphamide immunopo-
tentiation has been shown in the mouse and guinea pig 
to be a r egulator suppressor cell. In addition, we have 
induced in the hamster specific immune tolerance to 
dinitrochlorobenzene with dinitrobenzene sulfonate; in 
the mouse and guinea pig it has been demonstrated that 
the induction of specific immune tolerance to contact 
allergens by parenteral hapten involves the elaboration 
of specific suppressor cells. These findings, then, imply 
the existence of regulatory suppressor cells for T -cell 
phenomena in the hamster. This contrasts with reports 
that suppressor cell function in hamsters, as against 
other rodents, is defective as it relates to the regulation 
of, for instance, allogeneic r eactions, antibody formation 
and tolerance to contact allergens. 
Allergic contact dermati tis (ACD) has been studied in man 
as well as in a variety of laboratory animals including the guinea 
pig, mouse, rat and chicken; but, systematic studies of allergic 
contact dermatitis in Syrian hamsters are lacking. It has been 
suggested that the hamster is immunologically unique and 
evidence has been offered showing that that animal lacks reg· 
ulatory suppressor cells of T·cell phenomenon [1]. We have 
undertaken a study of ACD to low molecular weight compounds 
in the hamster. ACD can readily be induced in hamsters to 
strong contact allergens, and the acquisition of this sensitivity 
can be prevented by pretreatment with the relevant soluble 
hapten. A comparable induction of immune tolerance in other 
species involves regulatory suppressor cells [2-4]. Further, in 
the hamster, treatment before sensitization with cyclophospha-
mide intensifies the acquisition of ACD. It is known in other 
species, particularly in the guinea pig and in the mouse, that 
immunopotentiation by cyclophosphamide develops as a resul t 
of the inhibition of specific suppressor cells [5- 7]. It would seem 
that the hamster is not an immunologically unique animal in 
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terms of the regulation of the immune response to contact 
allergens by suppressor cells. Further, certain characteristics, 
e.g., its immunologically privileged cheek pouch , render the 
hamster especially suited for particular experimental studies of 
A CD. 
MATERIALS AND METHODS 
Hamsters 
We obtained female Syrian golden hamsters from Lakeview Labo-
ratories, Waltham, Massachusetts; the hamsters were 8-12 weeks old 
at the beginning of an experiment. Both the random bred LVG and the 
inbred MHA strains were used. The hamsters were housed 4 or 5 to a 
cage on wood shavings in a ligh t-cycled, temperature-controlled room. 
They were maintained on Purina Chow and acidified water. Losses 
from in tercurren t illness did not occur. 
Chemicals 
Oxazolone (4-ethoxymethylene 2-phenyl oxazolone) (BDH Chemi-
cals Ltd., Poole, E ngland.), DNCB (1-chloro, 2,4-dinitrobenzene) and 
DNBS0 3 (! -sulfonate, 2,4-dini trobenzene) (Eastman Chemicals, Roch-
ester, NY) were prepared [as fresh solut ions] immediately before use. 
Cyclophosphamide was obtained from the Mead-J ohnson Company, 
Indianapolis, Indiana. Cpmplete Freund's adjuvant (CFA) , conta ining 
1 mg/ml of heat-killed Mycobacterium. tuberculosis vaL butyricum, 
was purchased from Difco Laboratories, Detroit, Michigan. 
Sensitization 
Hamsters were sensitized by the application of a high concentration 
of DNCB or oxazolone in acetone, applied with a disposable glass 
pipette, to a clipped area on one flank. Cha llenge was made with a 
dilute, rela tively nonirri tating concentration of a llergen in a solution of 
4 parts acetone 1 part corn oil applied to an ear. Measurements were 
made of ear thickness with an engineer's micrometer before and at 
different times after the application of the challenge solution, following 
the technique of Asherson and P tak in the mouse [8]. The hamsters 
were ligh tly anaesthetized with diethyl ether for these procedw·es. 
Histology 
Under ether anaesthesia biopsy specimens were taken of the chal-
lenge sites in selected instances. The specimens were fiXed in 10% 
phosphate buffered formalin processed to histological sections and 
stained wit h hematoxylin and eosin by routine histopathological tech-
niques. 
Statistics 
Statistical differences were analyzed by a one-tailed Mann-Whitney 
U-tes t [9]. 
RESULTS 
Sensitization to Oxazolone and Immunopotentiation by 
Complete Freund's Adjuvant 
In a typical experiment, female LVG hamsters were divided 
into 3 groups of6 animals each. Group 1 received an intradermal 
injection of 0.1 ml of CFA into 2 adjacent sites on the left 
clipped flank. One hour later , these sites, as well as comparable 
clipped sites of a second group of hamsters, were cleansed with 
acetone, and received 0.02 ml of 5% oxazolone in acetone. Next 
day 0.02 ml of 5% oxazolone in acetone was again applied to the 
same sites in animals of Groups 1 and 2. On Day 7 the animals 
were challenged by the application of 0.015 ml of 1% oxazolone 
applied to the r ight ea1·. The base line as well as ' readings at 4, 
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24 and 48 hr were made. The protocol and the results of this 
experiment are shown in Table I. The hamsters had been 
successfully sensitized to oxazolone; pretreatment of the sensi-
tization site with CF A intensified the acquisition of the sensi-
tivity. The lack of a 4-hr reaction suggested that the phenom-
enon was not antibody mediated [10,11]. 
Irnmunopotentiation of ACD with Cyclophosphamide 
Inbred MHA female hamsters were divided into 3 groups. 
Group 1 was given cyclophosphamide 150 mg/ kg IP 3 days 
before sensitization. On Day 0, hamsters of Groups 1 and 2 were 
putatively sensitized to DNCB by 2 applications, 1 hr apart, of 
0.02 ml of 10% DNCB in acetone to a clipped site on the flank. 
The test animals were challenged, along with a toxicity control 
group, on Day 7 with 1% DNCB. The protocol and results of 
this experiment are shown in Table II. Pretreatment with 
cyclophosphamide substantially inhanced the acquisition of 
contact sensitivity to DNCB. (In each of 2 fmther experiments, 
one with DNCB and the other with oxazolone, a comparable 
immunopotent iation with cyclophosphamide was observed.) 
Biopsies of challenge sites were seem ed from 2 hamsters of 
each group and processed to slides that were then stained with 
hemotoxylin-eosin. The reactions of Groups I and II, which 
were clinically positive, were compared with those of Group III 
(toxicity control). The histopathology of the positive reactions 
showed the epidermis to be increased in thickness from 1-2 
cells to 4-6 cells. In addition, there was mild-to-moderate intra-
cellular edema and focal areas of spongiosis and exocytosis. In 
the dermis there was a diffuse infiltrate consisting of histocytes 
and lymphocytes. The ear cartilage appeared normal. The 
changes were more severe in the cyclophosphamide-potentiated 
hamsters, although, qualitatively the histopathological pictme 
was the same in the biopsies from Group I and Group II. We 
and others have seen a similar picture with allergic contact 
dermatitis in the mouse [2]. 
Induction of Specific Immune Tolerance to DNCB 
Six female LVG hamsters were injected intraperitoneally 
with DNBS03 (750 mg/ kg). One week later, these hamsters and 
a fmther group of naive hamsters were putatively sensitized to 
DNCB; both groups, as well as a toxicity-control group, were 
challenged with DNCB on the ear 7 days later. The protocol 
and results are outlined in Table III. The hamsters pretreated 
with DNBS03 were refractory to sensitization with DNCB. 
After the 24-hr reading of the DNCB challenge reactions, we 
sensitized hamsters of Groups I and II to oxazolone by applying 
0.02 ml of 5% oxazolone in acetone twice to a clipped site on the 
left flank. Five days later the hamsters of Groups I, II and III 
(from T able Ilia) were challenged on their previously unused 
right ear with 1% oxazolone. The protocol and results are 
outlined in Table Illb. The hamsters tolerized to DNCB could 
readily be sensitized to oxazolone; thus, their immunological 
TABLE I. Sensitization of hamsters to oxazolon e using complete Freund's adjuuant 
Group 
I. 
II. 
II. 
DayO 
CFA; oxaz. 
oxaz. 
Treatment 
Day 1 Day 7 
oxaz. oxaz. 
oxaz. chal-
lenge 
Increase in ear thickness X 10- 2 mm 
Day 7 DayS Day 9 +4 hi· 
2.3 ± 3.6" 23.1 ± 5.9 36.3 ± 7.7 
2.3 ± 3.6 4.8 ± 2.5 7.8 ± 3.4 
1.8 ± 2.7 0.5 ± 1.2 1.7±0.9 
Two groups of 6 hamsters were sensitized by applying 0.02 ml of 5% oxazolone (oxaz.) on 2 successive days to a clipped site on the left flank. 
The sensitization sites of hamsters of Group I had been injected intradermally with 0.1 ml of CF A 1 hr prior to the first sensitization injection. 
The results of challenge to the right eru· with 0.015 ml of 1% oxazolone are shown. A third, toxicity group was not sensitized. There were no 
s ignificant differences in the 4-hr reactions. At both 24 and 48 hr the reactions of the hrunsters ranked as follows: Group I > Group II > Group 
III; p < 0.01 in all cases. 
a Mean ± standard deviation. 
TABLE II. Immunopotentiation by cyclophosphamide of DNCB contact dermatitis 
Treatment Ear thickness X 10- 2 mm 
Group I 
Day -3 Day 0 Day 7 Base line (Day 7) Day 8 Day 9 
1 Cy DNCB DNCB 29.5 42.0 45.5 
2 l l chal- 29.5 56.0 60.5 3 lenge 30.5 53.0 57.5 4 1 29.5 41.5 44.0 5 27.5 36.5 34.5 
Group II 
1 DNCB DNCB 28.5 34.0 33.5 
2 l chal- 28.5 35.0 35.5 3 lenge 28.5 34.5 37.5 4 1 28.0 39.5 37.5 5 28.5 37.5 41.5 
Group III 
1 DNCB 27.5 28.5 29.5 
2 chal- 28.5 27.5 28.0 
3 lenge 29.5 28.5 28.5 
4 I 29.0 28.5 28.5 
Two groups of 5 female MHA hamsters were sensit ized by 2 applications, 1 hr apart, of 0.02 ml of 10% DNCB in acetone to a clipped site on 
the right flank. In addition, Gwup I hamsters had received cyclophosphamide 150 mg/ kg intraperitoneally 3 days previously. All hamsters, 
including a toxicity control group, were challenged on the left ear with ·0.015 ml of 1% DNCB. The measured thickness of the ear of each hamster 
prior to testing and at 24 hr and 48 hr post- testing is sh~wn . The intensity of the induced reactions was judged by the increase in ear thickness 
and the reactions in each group compared. At 24 hr, the reactions ranked as follows: Group 1 > Group II > Group III (p < 0.01). At 48 hr the 
reactions of Group I > Group II (p < .05) and the reactions of Group II > Group III (p < .01) . 
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TABLE Ilia. Induction of immune tolerance to DNCB 
Treatment Increase in ear thickness x 10- • mm. Group 
Day - 7 DayO Day 5 Day 6 Day 7 
I. DNBSO" DNCB DNCB 1.3 ± 0.7 2.5 ± 1.1 
II. sens. chal- 7.5 ± 3.4 6.6 ± 3.0 
III. lenge 1.8 ± 1.3 3.1 ± 2.2 
Two groups of 6 LVG female hamsters were sensitized to DNCB by 
applying 0.02 ml of 10% DNCB in acetone twice to a clipped site on the 
right flank on Day 0. In addition, Group I hamsters had received 
DNBS03 (750 mg/ kg), intraperltoneally, 7 days previously. The 2 
putatively sensitized groups of hamsters, as well as a toxicity control 
group, was ear challenged on Day 5 with 1% DNCB. The protocol and 
average 24 and 48 hr reactions are shown. The reactions of Group II 
were significantly larger than that of Group I at 24 hT (p < .01) and at 
48 hr (p < .05). 
I. 
II. 
TABLE Illb. Sensitization to oxazolone of hamsters tolerant to 
DNCB 
Increase in ear 
Trea tment thickness X 10-• 
Group m_m. 
Day 6 Day 11 Day 12 Day 13 
oxaz. oxaz. 7.0 ± 2.8 9.1 ± 5.3 
sens. chal- 4.9 ± 2.8 5.2 ± 3.8 
III. lenge 0.6 ± 1.3 -0.4 ± 0.6 
Two of the 3 groups of hamsters from Table Ilia were putatively 
sensitized to oxazolone (oxaz.) after the 24 hr reading of their DNCB 
reactions (on Day 6) by 2 successive applications of 5% oxazolone to a 
freshly clipped area on the left flank. Five days later the hamsters of all 
3 groups were challenged with 1% oxazolone on the right ear. The 
average 24 and 48 hr reactions are shown. The reactions of Group I and 
Group II are not statistically different. The reactions of hamsters of 
Group III were smaller than those of Group I or Group II (p < .01). 
tolerance was limited to DNCB. We h ave repeated this exper-
iment twice, with the same result. 
DISCUSSION 
The Syrian hamster can readily be sensitized to strong con-
tact allergens by a single, or better, several applications of a 
high concentration of allergen to the skin. As in t he guinea pig, 
pretreatment of the sensitized site with CF A heightens the 
acquisition of the sensit ization [12). Sensitivity can usually be 
demonstrated 4 (but not 3) days after the initial application of 
sensitizer; by 5 days post sensitization it can be observed in 
nearly all hamsters and is about at its maximum intensity. This 
sharp, early appearance of full-blown sensitivi ty is seen in other 
species, e.g., guinea pig and mouse, with strong sensitizers and 
contrasts with the more gradual appearance of antibody. Unlike 
the guinea pig, but similar to the mouse, rat and dog, the fla nk 
of the hamster was unsuitable as a challenge site; ear thickening 
proved to be, as in these other animals, an appropriate index of 
allergic inflammation. This restriction of challenge site follows 
from the relative failure of vasodilation of the cutaneous vessels 
in response to inflammatory stimuli in the hamster, mouse, etc., 
as against the guinea pig. Fundamental immunological distinc-
tions are not implied by this difference in vasomotor physiology. 
The histology of ACD reactions in the hamster was consistent 
with that seen in other animals. No attempt was made to 
determine the role of the basophil in these delayed reactions; 
histology more searching than th at of hematoxylin-eosin stain-
ing would be required [13). 
Some years ago we described th e heightened acquisition of 
ACD in the guinea pig when the animal was treated with 
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cyclophosphamide prior to contact sensitization and shortly 
thereafter Hunziger confirmed this observation [14,15]. Immu-
nopotentiation of the acq uisit ion of delayed-type hypersensitiv-
ity to low molecular weight allergens and to complete antigens 
has been extensively reported in the guinea pig and mouse 
[5,6,16,17). Analysis of the phenomenon indicates that cyclo-
phosphamide eliminates a precursor of a suppressor cell that 
otherwise would dull the expression of the hypersensitivity. 
There is evidence that this regulator cell, at least in th e mouse, 
is a T -cell [7]. In the hamster, immunopotentiation by cyclo-
phosphamide of the acq uisit ion of ACD is a consistent finding 
and conforms to that seen in the guinea pig and mouse. Implied, 
then, but not directly demonstrated, is a suppressor cell, prob-
ably a T-cell, that is the target for cyclophosphamide immu-
nopotentia tion. 
T he specific immune tolera nce that is induced by parenteral 
hapten a lso appears to be mediated by a suppressor T -cell. The 
phenomenon has been a nalyzed in depth in t he mouse a nd 
guinea pig [18). The induction of specific immune tolerance in 
t he hamster with DNBSOa is a regular phenomenon and the 
methodology congruent with that used in the mouse and guinea 
pig. This finding suggests that suppressor cells in the ha mster, 
comparable to those in the guinea pig and mouse, regulate t he 
acquisition of at least this form of immune tolerance to low 
molecular weigh t contact allergens. 
It remains for later experiments to m ore directly identify 
suppressor cells regula ting T-cell phenomena in the hamster. 
However, the existence of such regulatory suppressor cells is 
reasonably certain . Paradoxically, suppressor cells that modu-
late the graft versus host and mixed lymphocyte reactions have 
been demonstrated in the rat and mouse but were sought for 
and not found in the hamster. It may be that t he suppressor 
cells regulating these T -cell reactions r epresent a separate 
subpopulat ion, differe nt from those suppressor cells regulating 
ACD. Alternatively, t he different results in the hamster as 
against the mouse and guinea pig may be due to the known 
peculiarities of the hamster histocompatibility complex, or in-
deed, the finding may rest on trivial experimental differe nces 
between the ham ster and other rodents [19). 
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"Hormone Receptors and Function in Skin." 
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